Syndax Pharmaceuticals syndax.com


Public lists: BIO 2016 (619)

Syndax is a clinical stage biopharmaceutical company developing entinostat as a combination therapy in multiple cancer indications with an initial focus on tumors that have shown sensitivity to immunotherapy, including lung cancer, melanoma and triple negative breast cancer. Entinostat is an oral, small molecule drug candidate that has direct effects on both cancer cells and immune regulatory cells, potentially enhancing the body's immune response to tumors. Entinostat is being evaluated in a Ph...Show all

Syndax is a clinical stage biopharmaceutical company developing entinostat as a combination therapy in multiple cancer indications with an initial focus on tumors that have shown sensitivity to immunotherapy, including lung cancer, melanoma and tripl...Show all

Company (IPO / Went public)

Phone: 781-419-1400

Fax:

400 Totten Pond Road
Suite 140
Waltham, 02451
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Syndax Pharmaceuticals $227.2M Mar 3, 2016
Amplimmune Immunology $20M Oct 7, 2013
OncoMed Pharmaceuticals $376.2M Jul 18, 2013
See all 22 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Syndax Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 18 investors

Competitors

Company Status Description Investors
See all 22 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods for the treatment of lung cancer Dec 07, 2012 Application